RhumbLine Advisers’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.55M | Buy |
|
|||||
|
2023
Q3 | $1.93M | Buy |
|
|||||
|
2023
Q2 | $1.38M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $316K | Sell |
|
|||||
|
2021
Q4 | $357K | Sell |
|
|||||
|
2021
Q3 | $388K | Buy |
|
|||||
|
2021
Q2 | $454K | Sell |
|
|||||
|
2021
Q1 | $529K | Sell |
|
|||||
|
2020
Q4 | $700K | Buy |
|
|||||
|
2020
Q3 | $777K | Sell |
|
|||||
|
2020
Q2 | $424K | Buy |
|
|||||
|
2020
Q1 | $126K | Hold |
|
|||||
|
2019
Q4 | $166K | Sell |
|
|||||
|
2019
Q3 | $435K | Sell |
|
|||||
|
2019
Q2 | $613K | Buy |
|
|||||
|
2019
Q1 | $1.03M | Sell |
|
|||||
|
2018
Q4 | $613K | Buy |
|
|||||
|
2018
Q3 | $586K | Sell |
|
|||||
|
2018
Q2 | $742K | Buy |
|